Newly Formed Velsera Seeks Additional Acquisitions to Build Precision Medicine Platform
Newly formed precision medicine technology firm Velsera, incorporated through a merger of Pierian, Seven Bridges Genomics, and UgenTec, is not yet done with M&A activity to fuel its short-term growth. "We think before the end of the year, we may get another five or six acquisitions" to fill in missing pieces, said CEO Gavin [...]